APA (7th ed.) Citation

Akbari, N., & Saadat, M. (2025). No evidence for an association between the chemokine receptor 5 D32 polymorphism and multiple sclerosis susceptibility: A meta-analysis. Scripta Medica (English Edition), 56(1), 105-115. https://doi.org/10.5937/scriptamed56-54562

Chicago Style (17th ed.) Citation

Akbari, Nazanin, and Mostafa Saadat. "No Evidence for an Association Between the Chemokine Receptor 5 D32 Polymorphism and Multiple Sclerosis Susceptibility: A Meta-analysis." Scripta Medica (English Edition) 56, no. 1 (2025): 105-115. https://doi.org/10.5937/scriptamed56-54562.

MLA (9th ed.) Citation

Akbari, Nazanin, and Mostafa Saadat. "No Evidence for an Association Between the Chemokine Receptor 5 D32 Polymorphism and Multiple Sclerosis Susceptibility: A Meta-analysis." Scripta Medica (English Edition), vol. 56, no. 1, 2025, pp. 105-115, https://doi.org/10.5937/scriptamed56-54562.